Aquatic Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Aquatic Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,000	Closed	-$155K	–	1764
2023 Q2	$155K	Buy	+14,000	New	+$195K	0.01%	736
2023 Q1	–	Sell	-19,800	Closed	-$246K	–	1870
2022 Q4	$246K	Sell	19,800 -21,100	-52%	-$299K	0.02%	697
2022 Q3	$571K	Buy	40,900 +30,400	+290%	+$490K	0.06%	384
2022 Q2	$145K	Buy	10,500 +9,100	+650%	+$146K	0.05%	405
2022 Q1	$23K	Buy	+1,400	New	+$21.9K	0.03%	471

Other funds holding ICPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Aquatic Capital Management's ICPT Position: Q3 2023 in Review

Aquatic Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 14,000 shares — an estimated $155K sold.

Aquatic Capital Management first reported a position in ICPT in Q1 2022 and held it in 5 quarters. The position peaked at $571K in Q3 2022. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

Aquatic Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Aquatic Capital Management sold 14,000 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $155K.
Aquatic Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 5 quarters.
Aquatic Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $571K in Q3 2022.
146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Aquatic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.